These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2497570)
1. Effect of transplantation site and alpha L3T4 treatment on survival of rat, hamster, and rabbit islet xenografts in mice. Lacy PE; Ricordi C; Finke EH Transplantation; 1989 May; 47(5):761-6. PubMed ID: 2497570 [TBL] [Abstract][Full Text] [Related]
2. Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (hamster to mouse). Sullivan FP; Ricordi C; Hauptfeld V; Lacy PE Transplantation; 1987 Oct; 44(4):465-8. PubMed ID: 3118518 [TBL] [Abstract][Full Text] [Related]
3. Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Ricordi C; Lacy PE; Sterbenz K; Davie JM Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8080-4. PubMed ID: 3120184 [TBL] [Abstract][Full Text] [Related]
4. Effect of low-temperature culture and L3T4 antibody on the survival of pancreatic islets xenograft (fish to mouse). Morsiani E; Lacy PE Eur Surg Res; 1990; 22(2):78-85. PubMed ID: 2116970 [TBL] [Abstract][Full Text] [Related]
5. Induction of tolerance to islet xenografts in a concordant rat-to-mouse model. Goss JA; Nakafusa Y; Finke EH; Flye MW; Lacy PE Diabetes; 1994 Jan; 43(1):16-23. PubMed ID: 8262312 [TBL] [Abstract][Full Text] [Related]
6. Donor-specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: importance of low temperature culture and transplant site on induction and maintenance. Yasunami Y; Ryu S; Ueki M; Arima T; Kamei T; Tanaka M; Ikeda S Cell Transplant; 1994; 3(1):75-82. PubMed ID: 7512876 [TBL] [Abstract][Full Text] [Related]
7. Intratesticular transplants of islet xenografts (rat to mouse). Bobzien B; Yasunami Y; Majercik M; Lacy PE; Davie JM Diabetes; 1983 Mar; 32(3):213-6. PubMed ID: 6402406 [TBL] [Abstract][Full Text] [Related]
8. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway. Grochowiecki T; Gotoh M; Dono K; Takeda Y; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M Transplantation; 2000 Apr; 69(8):1567-71. PubMed ID: 10836363 [TBL] [Abstract][Full Text] [Related]
9. Prolongation of islet xenograft survival by in vitro culture of rat megaislets in 95% O2. Lacy PE; Finke EH; Janney CG; Davie JM Transplantation; 1982 Jun; 33(6):588-92. PubMed ID: 6808723 [TBL] [Abstract][Full Text] [Related]
10. Induction of immune unresponsiveness to concordant islet xenografts by intrahepatic preimmunization and transient immunosuppression. Goss JA; Finke EH; Flye MW; Lacy PE J Clin Invest; 1994 Mar; 93(3):1312-4. PubMed ID: 8132772 [TBL] [Abstract][Full Text] [Related]
11. Prolongation of islet xenograft survival (rat to mouse) by in vitro culture at 37 C. Yasunami Y; Lacy PE; Davie JM; Finke EH Transplantation; 1983 Apr; 35(4):281-4. PubMed ID: 6404026 [TBL] [Abstract][Full Text] [Related]
12. Demonstration of donor specific unresponsiveness in rat islet allografts: importance of transplant site for induction by cyclosporin A and maintenance. Kamei T; Yasunami Y Diabetologia; 1989 Nov; 32(11):779-85. PubMed ID: 2512192 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet xenografts at two different transplantation sites (renal subcapsular versus intraportal): comparison of graft survival and morphology. Jaeger C; Wöhrle M; Federlin K; Bretzel RG Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():123-8. PubMed ID: 8839268 [TBL] [Abstract][Full Text] [Related]
14. Successful transfer of immune unresponsiveness to concordant rat islet xenografts. Goss JA; Flye MW; Lacy PE Transplantation; 1996 Jan; 61(1):9-13. PubMed ID: 8560581 [TBL] [Abstract][Full Text] [Related]
15. Effect of transplantation site and culture pretreatment on islet xenograft survival (rat to mouse) in experimental diabetes without immunosuppression of the host. Jaeger C; Wöhrle M; Bretzel RG; Federlin K Acta Diabetol; 1994 Dec; 31(4):193-7. PubMed ID: 7888689 [TBL] [Abstract][Full Text] [Related]
16. FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. Yasunami Y; Ryu S; Kamei T Transplantation; 1990 Apr; 49(4):682-6. PubMed ID: 1691535 [TBL] [Abstract][Full Text] [Related]
17. The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. Ryu S; Yasunami Y Transplantation; 1991 Oct; 52(4):599-605. PubMed ID: 1718064 [TBL] [Abstract][Full Text] [Related]
18. Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site. Aebischer P; Lacy PE; Gerasimidi-Vazeou A; Hauptfeld V Diabetes; 1991 Apr; 40(4):482-5. PubMed ID: 2010049 [TBL] [Abstract][Full Text] [Related]
19. Mitomycin-C treatment followed by culture produces long-term survival of islet xenografts in a rat-to mouse model. Gunji T; Saito T; Sato Y; Matsuyama S; Ise K; Kimura T; Anazawa T; Gotoh M Cell Transplant; 2008; 17(6):619-29. PubMed ID: 18819250 [TBL] [Abstract][Full Text] [Related]